Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study on Central Venous Catheters (CVC). Initiated in June 2023, this study achieved its Last Subject Last Visit (LSLV) in January 2024.
Central Venous Catheters are essential in various critical care scenarios, facilitating the administration of treatments and monitoring of patients requiring long-term care.
The focus of any PMCF study is to evaluate the performance and safety of a medical device in real-world clinical settings.
If you are seeking a partner with a proven track record in conducting high-quality clinical studies for medical devices, Axcellant is your ideal choice. We are here to offer our extensive experience and specialized expertise to support your research objectives.
Whether it’s navigating the complexities of study design, execution, or compliance, our team is equipped to deliver excellence and drive your projects to success.
We invite anyone looking for an experienced partner in medical device research to reach out. Our experience spans various types of studies, from pivotal trials to PMCF studies, all aimed at enhancing patient care through innovation and evidence-based research. Let’s discuss how we can collaborate to achieve outstanding outcomes in your next clinical study.
For further details about our services or to explore potential collaborations, please do not hesitate to contact us.
Patrycja Buczak-Kula
Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…
The EU is moving forward with key upgrades to its medical device and diagnostics regulations, specifically under the Medical Device…
Gene therapies now account for most ATMP clinical trials, with a balanced distribution between in vivo and ex vivo approaches.…
Copyright @ 2025 Axcellant